CytomX Therapeutics (CTMX)
(Delayed Data from NSDQ)
$1.15 USD
-0.04 (-3.36%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $1.16 +0.01 (0.87%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Fundamental Charts
About Debt to Equity Ratio (Quarterly)
The Company's quarterly Debt to Equity Ratio (D/E ratio) is Total Long Term Debt divided by total shareholder equity. It's used to help gauge a company's financial health. A higher number means the company has more debt to equity, whereas a lower number means it has less debt to equity. A D/E ratio of 1 means its debt is equivalent to its common equity. Take note that some businesses are more capital intensive than others.